Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1987
Characterization and biologic activities of an anti-idiotype-specific T cell line and its derived clonesE Mozes, H ZingerAnnals of the Rheumatic Diseases|March 14, 2003
Beneficial effects of the anti-oestrogen tamoxifen on systemic lupus erythematosus of (NZBxNZW)F1 female mice are associated with specific reduction of IgG3 autoantibodiesZ M Sthoeger, H Zinger, E MozesCellular Immunology|January 10, 1996
Effect of injection of anti-CD4 and anti-CD8 monoclonal antibodies on the development of experimental systemic lupus erythematosus in miceP J Ruiz, H Zinger, E MozesImmunology Letters|June 1, 1994
Induction of experimental systemic lupus erythematosus in mice by immunization with the F(ab')2 fragment of the human anti-DNA monoclonal antibody carrying the 16/6 idiotypeP J Ruiz, H Zinger, E MozesJournal of Clinical Immunology|September 1, 1992
The influence of aging on the induction and manifestations of experimental systemic lupus erythematosusR Segal, A Globerson, H Zinger, et al.Cellular Immunology|November 18, 2000
A peptide based on the sequence of the CDR3 of a murine anti-DNA mAb is a better modulator of experimental SLE than its single amino acid-substituted analogsN Brosh, H Zinger, M Fridkin, et al.Lupus|March 13, 2001
Suppression of experimental systemic lupus erythematosus (SLE) in mice via TNF inhibition by an anti-TNFalpha monoclonal antibody and by pentoxiphyllineR Segal, M Dayan, H Zinger, et al.Immunology Letters|May 8, 1999
DNA levels in immune complexes circulating in mice with induced systemic lupus erythematosusR Nezlin, M Dayan, H Zinger, et al.Journal of Clinical Immunology|August 12, 2000
Prevention of systemic lupus erythematosus-like disease in (NZBxNZW)F1 mice by treating with CDR1- and CDR3-based peptides of a pathogenic autoantibodyE Eilat, H Zinger, A Nyska, et al.Immunology|February 26, 2000
Characterization and role in experimental systemic lupus erythematosus of T-cell lines specific to peptides based on complementarity-determining region-1 and complementarity-determining region-3 of a pathogenic anti-DNA monoclonal antibodyN Brosh, E Eilat, H Zinger, et al.Pageof 4